Emerald Mutual Fund Advisers Trust Alnylam Pharmaceuticals, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

  • $1.77 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Jan 29, 2021
SELL
$122.97 - $147.0 $102,311 - $122,304
-832 Closed
0 $0
Q3 2020

Oct 28, 2020
SELL
$121.19 - $165.49 $1,817 - $2,482
-15 Reduced 1.77%
832 $121,000
Q2 2020

Jul 28, 2020
BUY
$104.21 - $156.44 $88,265 - $132,504
847 New
847 $125,000
Q1 2020

Apr 30, 2020
SELL
$93.12 - $133.99 $93,306 - $134,257
-1,002 Closed
0 $0
Q4 2019

Jan 29, 2020
BUY
$74.51 - $124.23 $74,659 - $124,478
1,002 New
1,002 $115,000

Others Institutions Holding ALNY

# of Institutions
644
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email